Skip to main content
OpenTrials

Clinical trial condition

Tuberculosis

Explore clinical trials studying Tuberculosis. Study availability and eligibility vary by location and protocol.

896 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Tuberculosis trial results

Completed

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

NCT01574638

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
  • Chapel Hill CRS Chapel Hill, North Carolina, United States
  • Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States
View Trial Details
Completed

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

NCT01751568

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Soweto IMPAACT CRS Johannesburg, Gauteng, South Africa
  • Wits RHI Shandukani Research Centre CRS Johannesburg, Gauteng, South Africa
  • Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS Cape Town, Western Cape, South Africa
  • Famcru Crs Cape Town, Western Cape, South Africa
View Trial Details
Completed

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

NCT01494038

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Gaborone CRS Gaborone, Botswana
  • Molepolole CRS Gaborone, Botswana
  • Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS Port-au-Prince, Haiti
  • Byramjee Jeejeebhoy Medical College (BJMC) CRS Pune, Maharashtra, India
View all 13 locations
View Trial Details
Completed

Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

NCT01571414

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
  • Ohio State University CRS Columbus, Ohio, United States
  • Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States
View Trial Details
Completed

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

NCT01404312

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

NCT02651259

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS Port-au-Prince, Haiti
  • Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho CRS Kericho, Kenya
  • Malawi CRS Lilongwe, Central Malawi, Malawi
  • Siriraj Hospital ,Mahidol University NICHD CRS Bangkok, Bangkoknoi, Thailand
View Trial Details
Completed

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

NCT00000959

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +21 more
Locations
  • UCLA Med Ctr Los Angeles, California, United States
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Hill Health Corp New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Completed

The Treatment of Tuberculosis in HIV-Infected Patients

NCT00001033

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +25 more
Locations
  • USC CRS Los Angeles, California, United States
  • Howard University Hosp., Div. of Infectious Diseases, ACTU Washington D.C., District of Columbia, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View Trial Details
Completed

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

NCT00000796

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +25 more
Locations
  • Cook County Hosp Chicago, Illinois, United States
  • Henry Ford Hosp Detroit, Michigan, United States
  • Interfaith Med Ctr Brooklyn, New York, United States
  • SUNY / Health Sciences Ctr at Brooklyn Brooklyn, New York, United States
View all 21 locations
View Trial Details

Related conditions